Literature DB >> 25242319

HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.

Tingting Li1, Xinghua Li2, Long Zhang1, Linchong Sun1, Xiaoping He1, Xiuying Zhong1, Dongya Jia1, Libing Song2, Gregg L Semenza3, Ping Gao1, Huafeng Zhang4.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) mediates a metabolic switch that blocks the conversion of pyruvate to acetyl-CoA in cancer cells. Here, we report that HIF-1α also inhibits fatty acid β-oxidation (FAO), another major source of acetyl-CoA. We identified a PGC-1β-mediated pathway by which HIF-1 inhibits the medium- and long-chain acyl-CoA dehydrogenases (MCAD and LCAD), resulting in decreased reactive oxygen species levels and enhanced proliferation. Surprisingly, we further uncovered that blocking LCAD, but not MCAD, blunts PTEN expression and dramatically affects tumor growth in vivo. Analysis of 158 liver cancer samples showed that decreased LCAD expression predicts patient mortality. Altogether, we have identified a previously unappreciated mechanism by which HIF-1 suppresses FAO to facilitate cancer progression.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242319     DOI: 10.1016/j.celrep.2014.08.028

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  128 in total

Review 1.  Exercise as Adjunct Therapy in Cancer.

Authors:  Kathleen A Ashcraft; Allison Betof Warner; Lee W Jones; Mark W Dewhirst
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 2.  Endothelial cell metabolism in health and disease: impact of hypoxia.

Authors:  Brian W Wong; Elke Marsch; Lucas Treps; Myriam Baes; Peter Carmeliet
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

Review 3.  Subcellular Energetics and Metabolism: A Cross-Species Framework.

Authors:  Robert H Thiele
Journal:  Anesth Analg       Date:  2017-06       Impact factor: 5.108

4.  Inactivation of MAPK in epididymal fat and amelioration of triglyceride secretion by injection of GRK2 siRNA in ob/ob mice.

Authors:  Kumiko Taguchi; Nanami Bessho; Mari Hida; Haruka Narimatsu; Takayuki Matsumoto; Tsuneo Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-26       Impact factor: 3.000

Review 5.  Dysregulated fatty acid metabolism in hepatocellular carcinoma.

Authors:  Mingda Wang; Jun Han; Hao Xing; Han Zhang; Zhenli Li; Lei Liang; Chao Li; Shuyang Dai; Mengchao Wu; Feng Shen; Tian Yang
Journal:  Hepat Oncol       Date:  2017-06-30

Review 6.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

7.  Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP-1.

Authors:  Yang Zhang; Chenchen Li; Chuanzhen Hu; Qian Wu; Yongping Cai; Songge Xing; Hui Lu; Lin Wang; Linchong Sun; Tingting Li; Xiaoping He; Xiuying Zhong; Junfeng Wang; Ping Gao; Zachary J Smith; Weidong Jia; Huafeng Zhang
Journal:  EMBO Rep       Date:  2019-08-05       Impact factor: 8.807

Review 8.  Molecular mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

9.  pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner.

Authors:  Jianping Guo; Abhishek A Chakraborty; Pengda Liu; Wenjian Gan; Xingnan Zheng; Hiroyuki Inuzuka; Bin Wang; Jinfang Zhang; Linli Zhang; Min Yuan; Jesse Novak; Jin Q Cheng; Alex Toker; Sabina Signoretti; Qing Zhang; John M Asara; William G Kaelin; Wenyi Wei
Journal:  Science       Date:  2016-08-26       Impact factor: 47.728

Review 10.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.

Authors:  Zhaoyong Li; Huafeng Zhang
Journal:  Cell Mol Life Sci       Date:  2015-10-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.